Zealand to regain control of elsiglutide
Zealand to regain control of elsiglutide Helsinn returns elsiglutide to Zealand Zealand now has full rights to develop products within cancer-supportive care Lugano, Switzerland and Copenhagen, Denmark, June 12, 2017 - Helsinn, the Swiss pharmaceutical …